Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project

AJ. Cruz-Jentoft, J. Daragjati, L. Fratiglioni, S. Maggi, AA. Mangoni, F. Mattace-Raso, M. Paccalin, MC. Polidori, E. Topinkova, L. Ferrucci, A. Pilotto, MPI_AGE Investigators,

. 2020 ; 32 (5) : 861-868. [pub] 20200316

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025031
E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem

Odkazy

PubMed 32180170
DOI 10.1007/s40520-020-01516-0
Knihovny.cz E-zdroje

MPI_AGE is a European Union co-funded research project aimed to use the Multidimensional Prognostic Index (MPI), a validated Comprehensive Geriatric Assessment (CGA)-based prognostic tool, to develop predictive rules that guide clinical and management decisions in older people in different European countries. A series of international studies performed in different settings have shown that the MPI is useful to predict mortality and risk of hospitalization in community-dwelling older subjects at population level. Furthermore, studies performed in older people who underwent a CGA before admission to a nursing home or receiving homecare services showed that the MPI successfully identified groups of persons who could benefit, in terms of reduced mortality, of specific therapies such as statins in diabetes mellitus and coronary artery disease, anticoagulants in atrial fibrillation and antidementia drugs in cognitive decline. A prospective trial carried out in nine hospitals in Europe and Australia demonstrated that the MPI was able to predict not only in-hospital and long-term mortality, but also institutionalization, re-hospitalization and receiving homecare services during the one-year follow-up after hospital discharge. The project also explored the association between MPI and mortality in hospitalized older patients in need of complex procedures such as transcatheter aortic valve implantation or enteral tube feeding. Evidence from these studies has prompted the MPI_AGE Investigators to formulate recommendations for healthcare providers, policy makers and the general population which may help to improve the cost-effectiveness of appropriate health care interventions for older patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025031
003      
CZ-PrNML
005      
20201222160050.0
007      
ta
008      
201125s2020 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s40520-020-01516-0 $2 doi
035    __
$a (PubMed)32180170
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Cruz-Jentoft, Alfonso J $u Servicio de Geriatría, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
245    10
$a Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project / $c AJ. Cruz-Jentoft, J. Daragjati, L. Fratiglioni, S. Maggi, AA. Mangoni, F. Mattace-Raso, M. Paccalin, MC. Polidori, E. Topinkova, L. Ferrucci, A. Pilotto, MPI_AGE Investigators,
520    9_
$a MPI_AGE is a European Union co-funded research project aimed to use the Multidimensional Prognostic Index (MPI), a validated Comprehensive Geriatric Assessment (CGA)-based prognostic tool, to develop predictive rules that guide clinical and management decisions in older people in different European countries. A series of international studies performed in different settings have shown that the MPI is useful to predict mortality and risk of hospitalization in community-dwelling older subjects at population level. Furthermore, studies performed in older people who underwent a CGA before admission to a nursing home or receiving homecare services showed that the MPI successfully identified groups of persons who could benefit, in terms of reduced mortality, of specific therapies such as statins in diabetes mellitus and coronary artery disease, anticoagulants in atrial fibrillation and antidementia drugs in cognitive decline. A prospective trial carried out in nine hospitals in Europe and Australia demonstrated that the MPI was able to predict not only in-hospital and long-term mortality, but also institutionalization, re-hospitalization and receiving homecare services during the one-year follow-up after hospital discharge. The project also explored the association between MPI and mortality in hospitalized older patients in need of complex procedures such as transcatheter aortic valve implantation or enteral tube feeding. Evidence from these studies has prompted the MPI_AGE Investigators to formulate recommendations for healthcare providers, policy makers and the general population which may help to improve the cost-effectiveness of appropriate health care interventions for older patients.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a analýza nákladů a výnosů $7 D003362
650    _2
$a ženské pohlaví $7 D005260
650    12
$a křehký senior $7 D016330
650    _2
$a geriatrické hodnocení $7 D015577
650    _2
$a hospitalizace $x ekonomika $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a samostatný způsob života $7 D057187
650    _2
$a mužské pohlaví $7 D008297
650    12
$a multimorbidita $7 D000076322
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Daragjati, Julia $u Geriatrics Unit, San Antonio Hospital, Padua, Italy.
700    1_
$a Fratiglioni, Laura $u Aging Research Center, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet and Stockholm University, Stockholm, Sweden.
700    1_
$a Maggi, Stefania $u Aging Section, National Research Council, Padua, Italy.
700    1_
$a Mangoni, Arduino A $u Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders Medical Centre, Flinders University, Adelaide, Australia.
700    1_
$a Mattace-Raso, Francesco $u Erasmus University Medical Center, Rotterdam, The Netherlands.
700    1_
$a Paccalin, Marc $u Geriatrics Department, University Hospital Poitiers and Centre Investigation Clinique 1402, University of Poitiers, CHU Poitiers, INSERM, Poitiers, France.
700    1_
$a Polidori, Maria Cristina $u Ageing Clinical Research, Dpt. II of Internal Medicine and Center of Molecular Medicine, University of Cologne Medical Faculty, Cologne, Germany.
700    1_
$a Topinkova, Eva $u First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Ferrucci, Luigi $u National Institute on Aging, Baltimore, MD, USA.
700    1_
$a Pilotto, Alberto $u Department of Geriatric Care, Orthogeriatrics and Rehabilitation, E.O. Galliera Hospital, Mura delle Cappuccine 14, 16128, Genoa, Italy. alberto.pilotto@galliera.it. Department of Interdisciplinary Medicine, University of Bari, Bari, Italy. alberto.pilotto@galliera.it.
710    2_
$a MPI_AGE Investigators
773    0_
$w MED00159812 $t Aging clinical and experimental research $x 1720-8319 $g Roč. 32, č. 5 (2020), s. 861-868
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32180170 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222160046 $b ABA008
999    __
$a ok $b bmc $g 1599176 $s 1115717
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 32 $c 5 $d 861-868 $e 20200316 $i 1720-8319 $m Aging Clinical and Experimental Research $n Aging Clin Exp Res $x MED00159812
LZP    __
$a Pubmed-20201125
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace